Loading insider details...
Beta
Latest Form 4 (Jun 22, 2026): Grant/Award of 20,706 KARD shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | Kardigan, Inc. (KARD) | Grant/Award | 20,706 | n/a |
| Jun 18, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/Award | 3,772 | n/a |
| Jun 4, 2026 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/Award | 7,490 | n/a |
| Jun 2, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 3,977 | n/a |
| May 12, 2026 | Odyssey Therapeutics, Inc. (ODTX) | Grant/Award | 27,393 | n/a |
| Jun 16, 2025 | Century Therapeutics, Inc. (IPSC) | Grant/Award | 44,000 | n/a |
| Jun 10, 2025 | Sagimet Biosciences Inc. (SGMT) | Grant/Award | 32,250 | n/a |
| Jun 2, 2025 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 5,703 | n/a |
| May 22, 2025 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/Award | 6,650 | n/a |
| Feb 26, 2025 | BIOMARIN PHARMACEUTICAL INC (BMRN) | Grant/Award | 3,130 | n/a |